1969
DOI: 10.1001/jama.1969.03150190037007
|View full text |Cite
|
Sign up to set email alerts
|

Rheumatic Fever Following Streptococcal Vaccination

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
56
0
2

Year Published

1983
1983
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 127 publications
(58 citation statements)
references
References 13 publications
0
56
0
2
Order By: Relevance
“…The vaccine was given to siblings in families with rheumatic fever. There were three episodes of rheumatic fever in the vaccinees, but it was not certain if the vaccine was related to the development of rheumatic fever (350). In the study, 3 of 21 vaccinees developed rheumatic fever following group A streptococcal infections occurring during the period of immunization.…”
Section: Antibiotic Therapy and Prophylaxismentioning
confidence: 81%
“…The vaccine was given to siblings in families with rheumatic fever. There were three episodes of rheumatic fever in the vaccinees, but it was not certain if the vaccine was related to the development of rheumatic fever (350). In the study, 3 of 21 vaccinees developed rheumatic fever following group A streptococcal infections occurring during the period of immunization.…”
Section: Antibiotic Therapy and Prophylaxismentioning
confidence: 81%
“…Initial attempts at developing a vaccine against group A streptococcal infection failed when vaccinated subjects developed acute rheumatic fever after vaccination. (9) Despite a better understanding of vaccine design the authors of a recent paper expressed disappointment that only one vaccine has been studied clinically in the last 3 decades. (10) The accurate identification of the multiple serotypes causing acute rheumatic fever in various parts of the globe has raised concerns regarding the potential effectiveness of the current multivalent vaccine.…”
Section: The Current Status Of Primary Prevention and Vaccinationmentioning
confidence: 99%
“…However, when injected with mineral oil adjuvant, partially purified M protein induced bactericidal antibodies in 10 of 16 subjects [41], suggesting that a vaccine based on M protein may be an effective strategy if a safe and reliable delivery system is identified. Unfortunately, progress in clinical vaccine development faltered when investigators conducting a clinical trial involving a partially purified M3 protein reported an apparent increase in the attack rate of ARF among vaccinated children compared with historical controls [42]. Whether these cases were caused by vaccination remains uncertain.…”
Section: The History Of Clinical Gas Vaccine Trialsmentioning
confidence: 99%